Migration arrest of chemoresistant leukemia cells mediated by MRTF-SRF pathway
暂无分享,去创建一个
S. Seno | M. Ishii | D. Okuzaki | D. Motooka | Hiroki Mizuno | T. Sudo | J. Kikuta | Erika Yamashita | Maho Morimatsu
[1] G. Pruessner,et al. Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging , 2018, Immunology and cell biology.
[2] C. Lo Celso,et al. The interplay of leukemia cells and the bone marrow microenvironment. , 2018, Blood.
[3] M. Scott,et al. Non-canonical hedgehog pathway activation by MKL1/SRF promotes drug-resistance in basal cell carcinomas , 2018, Nature Medicine.
[4] Catriona McLean,et al. Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML , 2018, Cell stem cell.
[5] S. Shroff,et al. Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis , 2017, Angiogenesis.
[6] A. Reinisch,et al. Sticking It to the Niche: CD98 Mediates Critical Adhesive Signals in AML. , 2016, Cancer cell.
[7] C. Chuah,et al. CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. , 2016, Cancer cell.
[8] Malgorzata Nowicka,et al. T cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments , 2016, Nature.
[9] A. Sánchez-Aguilera,et al. The hematopoietic stem-cell niche in health and leukemia , 2016, Cellular and Molecular Life Sciences.
[10] M. Andreeff,et al. Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang , 2016, Cancer biology & medicine.
[11] Daniel J Weisdorf,et al. Acute Myeloid Leukemia. , 2015, The New England journal of medicine.
[12] R. Neubig,et al. Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents. , 2013, Bioorganic & medicinal chemistry letters.
[13] M. Ishii,et al. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D , 2013, Proceedings of the National Academy of Sciences.
[14] Masaru Ishii,et al. Dynamic visualization of RANKL and Th17-mediated osteoclast function. , 2013, The Journal of clinical investigation.
[15] T. Naoe,et al. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study. , 2011, Blood.
[16] M. Ishii,et al. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo , 2010, The Journal of experimental medicine.
[17] D. Scadden,et al. The leukemic stem cell niche: current concepts and therapeutic opportunities. , 2009, Blood.
[18] M. Ishii,et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis , 2009, Nature.
[19] Erik Sahai,et al. Myocardin-Related Transcription Factors and SRF are required for cytoskeletal dynamics, invasion and experimental metastasis , 2009, Nature Cell Biology.
[20] Satoshi Tanaka,et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.
[21] S. Lowe,et al. Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. , 2006, Experimental hematology.
[22] D. Gilliland,et al. Drug therapy for acute myeloid leukemia. , 2005, Blood.
[23] R. Treisman,et al. Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MAL , 2003, Cell.
[24] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[25] H. Kantarjian,et al. Acute myeloid leukemia , 2018, Methods in Molecular Biology.
[26] J. Downing,et al. Acute myeloid leukemia. , 1999, The New England journal of medicine.
[27] M. Nikolova,et al. Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia. , 1998, Leukemia research.